ACSL3

Fatty acid CoA ligase Acsl3 · O95573 · ACSL3 on Sugi Atlas →

251 patent compounds predicted against ACSL3, 187 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL24634565 SCHEMBL24634565 1.00 1/20
SCHEMBL26780273 SCHEMBL26780273 1.00 1/20
SCHEMBL27256174 SCHEMBL27256174 0.81 1/20
SCHEMBL27256207 SCHEMBL27256207 0.81 1/20
SCHEMBL24634626 SCHEMBL24634626 0.74 1/20
SCHEMBL27256210 SCHEMBL27256210 0.69 1/20
SCHEMBL9413588 SCHEMBL9413588 0.60 1/20
SCHEMBL24634557 SCHEMBL24634557 0.56 1/20
SCHEMBL1247012 SCHEMBL1247012 0.56 1/20
SCHEMBL1794125 SCHEMBL1794125 0.56 1/20
SCHEMBL1794127 SCHEMBL1794127 0.56 1/20
SCHEMBL1794239 SCHEMBL1794239 0.56 1/20
SCHEMBL10614660 SCHEMBL10614660 0.55 1/20
SCHEMBL25524814 SCHEMBL25524814 0.55 1/20
Trifluoroacetic Acid Trifluoroacetic Acid (SCHEMBL1794473) 0.55 1/20
Trifluoroacetic Acid Trifluoroacetic Acid (SCHEMBL1796405) 0.55 1/20
SCHEMBL28424879 SCHEMBL28424879 0.55 1/20
SCHEMBL29972870 SCHEMBL29972870 0.55 1/20
SCHEMBL1749499 SCHEMBL1749499 0.55 1/20
SCHEMBL20594364 SCHEMBL20594364 0.54 1/20

Clinical trials — most relevant to ACSL3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Fenofibrate Therapy in Diabetic Nephropathy PHASE3UNKNOWN
Comparison of Coenzyme A and Pantethine Capsule for Safety and Efficacy On Patients With Hyperlipidemia PHASE3COMPLETED
Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease PHASE2COMPLETED
Effect of Insulin Lowering on Lipogenesis PHASE1RECRUITING
Liver Positron Emission Tomography (PET) Study of Non Alcoholic Fatty Liver Disease EARLY_PHASE1COMPLETED
Androgens and NAFLD Longitudinal Cohort Study nanRECRUITING
Impact Of Choline in Patients With NAFLD nanUNKNOWN
Familial Partial Lipodystrophy Study nanCOMPLETED
Use of MCT Oil for Enhancement of Weight Loss in Obese Patients nanCOMPLETED
Frequency of Metabolic Dysfunction Associated Fatty Liver Disease in Patients With Acute Coronary Syndromes nanNOT_YET_RECRUITING
Fatty Acid Metabolism and Insulin Sensitivity: the Role of Endurance Exercise nanCOMPLETED
Fatty Acid Oxidation Defects and Insulin Sensitivity nanCOMPLETED
Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study nanCOMPLETED
The Effect of Bariatric Surgery on Insulin Sensitivity and Energy Metabolism nanRECRUITING
Effect of Dietary SFA and Fructose on Hepatic Insulin Sensitivity nanCOMPLETED
Abnormalities in the Effects of Insulin and Exercise on Glucose- and Lipid Metabolism in Obesity and Type 2 Diabetes nanCOMPLETED
The Roles of SAH Gene Family in Athrogenic Dyslipidemia in Postmenopausal Women nanUNKNOWN
Screening of Healthy Adults for Genetic Variations That Control Fatty Acid Processing nanCOMPLETED
NASH AMPK Exercise Dosing (AMPED) Trial nanRECRUITING
Effect of Omega-3 Fatty Acids Supplementation on Hypertriglyceridemia in Pediatric Patients With Obesity. nanCOMPLETED
Omega-3 vs Very Low Calorie Diet for Liver Size Reduction nanUNKNOWN
De Novo Lipogenesis in Severity of NAFLD nanCOMPLETED
Promotion of Weight Management nanACTIVE_NOT_RECRUITING
Hepatic Glycogen and Fat Oxidation nanCOMPLETED
Role of Dairy Products in Weight Maintenance nanCOMPLETED
Effect of Age on Glucose and Lipid Metabolism nanCOMPLETED
Glycemic Index/Saturated Fatty Acid Diet and Hepatic Fat nanCOMPLETED
De Novo Lipogenesis and Insulin Sensitivity in Obese nanCOMPLETED
Gene Expression in Obesity and Insulin Resistance nanCOMPLETED
Hepatic Energy Fluxes in NASH and NAS Patients nanACTIVE_NOT_RECRUITING

Related proteins — ESM-2 sequence neighbours (a ACSL3 binder may also engage these)

ProteinNameSimilarity
Q5R668 1.000 Q5R668 →
Q9CZW4 1.000 Q9CZW4 →
Q63151 1.000 Q63151 →
Q9QUJ7 1.000 Q9QUJ7 →
O35547 1.000 O35547 →
ACSL4 Long-chain-fatty-acid--CoA ligase 4 1.000 landscape →
Q9CAP8 0.996 Q9CAP8 →
Q8LKS5 0.993 Q8LKS5 →
P30624 0.992 P30624 →
M4ISH1 0.991 M4ISH1 →
Q2XU92 0.990 Q2XU92 →
Q8LPS1 0.990 Q8LPS1 →
Q9P7D7 0.990 Q9P7D7 →
Q5FVE4 0.990 Q5FVE4 →
Q9SJD4 0.990 Q9SJD4 →
Q55DR6 0.989 Q55DR6 →
Q9C7W4 0.989 Q9C7W4 →
Q9T009 0.988 Q9T009 →
O60135 0.988 O60135 →
O22898 0.987 O22898 →
Q9T0A0 0.986 Q9T0A0 →
O88813 0.985 O88813 →
O24146 0.985 O24146 →
Q8JZR0 0.985 Q8JZR0 →
P39002 0.984 P39002 →
ACSL5 Long-chain-fatty-acid--CoA ligase 5 0.984 landscape →
O24540 0.984 O24540 →
P31685 0.984 P31685 →
Q9XIA9 0.984 Q9XIA9 →
A1L1K7 0.983 A1L1K7 →